Chronic graft versus host disease (GVHD) is a major cause of morbidity and mortality after
allogeneic hematopoietic cell transplantation. Clinically, chronic GVHD is a pleiotropic …

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

PURPOSE The rho-associated coiled-coil–containing protein kinase-2 (ROCK2) signaling
pathway regulates the Th17/regulatory T cells balance and controls profibrotic pathways …

Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

Chronic graft-versus-host disease (GVHD) remains a common and potentially life-
threatening complication of allogeneic hematopoietic stem cell transplantation (HCT). The 2 …

Advances in hematopoietic cell transplantation (HCT) technology and supportive care
techniques have led to improvements in long-term survival after HCT. Emerging indications …

Quality of life (QOL) after hematopoietic cell transplantation (HCT) is compromised by
chronic GVHD. In a prospectively assembled multicenter cohort of adults with chronic GVHD …

Graft-versus-host disease (GVHD) is an immunological reaction and a frequent complication
following allogeneic hematopoietic stem cell transplantation. It is associated with high …

Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to
demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we …

Steroid refractory chronic graft-versus-host disease (cGVHD) is associated with a significant
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …